AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention

Recruiting now · Not applicable

Conditions studied: Coronary Artery Disease

In brief

AI INFORM is a multicenter randomized trial that will test the hypothesis that providing clinicians information on the presence and amount of coronary artery calcifications (CAC), will result in initiation or intensification of preventive therapies. The study will use a cloud-based artificial intelligence (AI) platform (Nanox.AI) that can analyze non contrast chest CT and estimate the amount of CAC.

Key facts

Study ID

NCT06235112

Run by

Brigham and Women's Hospital

People needed

1500

Starts

2024-07-31

Expected to finish

2027-12-01

Last updated by the study team

2026-01-23

Who can join

Age: 40 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients aged between 40-75 with prior chest CT within last 3 years

You may not qualify if…

• Prior coronary artery disease
• Prior cancer
• Other life-limiting condition

Where it is running

• Brigham and Women's Hospital — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.